ATE554071T1 - Herstellung chinolin-substituierter carbonat- und carbamat-derivate - Google Patents

Herstellung chinolin-substituierter carbonat- und carbamat-derivate

Info

Publication number
ATE554071T1
ATE554071T1 AT00942823T AT00942823T ATE554071T1 AT E554071 T1 ATE554071 T1 AT E554071T1 AT 00942823 T AT00942823 T AT 00942823T AT 00942823 T AT00942823 T AT 00942823T AT E554071 T1 ATE554071 T1 AT E554071T1
Authority
AT
Austria
Prior art keywords
carbamat
quinoline
derivatives
production
substituted carbonate
Prior art date
Application number
AT00942823T
Other languages
English (en)
Inventor
Michael Allen
Ramiya Premchandran
Sou-Jen Chang
Stephen Condon
John Demattei
Steven King
Lawrence Kolaczkowski
Sukumar Manna
Paul J Nichols
Hemant Patel
Subhash Patel
Daniel Plata
Eric Stoner
Jien-Heh Tien
Steven WITTENBERGER
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of ATE554071T1 publication Critical patent/ATE554071T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C68/00—Preparation of esters of carbonic or haloformic acids
    • C07C68/06—Preparation of esters of carbonic or haloformic acids from organic carbonates

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Saccharide Compounds (AREA)
AT00942823T 1999-06-24 2000-06-15 Herstellung chinolin-substituierter carbonat- und carbamat-derivate ATE554071T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14104299P 1999-06-24 1999-06-24
PCT/US2000/016404 WO2001000582A1 (en) 1999-06-24 2000-06-15 Preparation of quinoline-substituted carbonate and carbamate derivatives

Publications (1)

Publication Number Publication Date
ATE554071T1 true ATE554071T1 (de) 2012-05-15

Family

ID=22493906

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00942823T ATE554071T1 (de) 1999-06-24 2000-06-15 Herstellung chinolin-substituierter carbonat- und carbamat-derivate

Country Status (16)

Country Link
US (4) US6417366B2 (de)
EP (3) EP2409964B1 (de)
JP (2) JP4724337B2 (de)
KR (1) KR100666291B1 (de)
CN (2) CN100355734C (de)
AT (1) ATE554071T1 (de)
AU (1) AU784291B2 (de)
CA (3) CA2368768C (de)
CY (2) CY1113070T1 (de)
DK (2) DK1192139T3 (de)
ES (3) ES2385963T3 (de)
HK (1) HK1047089B (de)
IL (4) IL146475A0 (de)
MX (1) MXPA01013209A (de)
PT (2) PT1192139E (de)
WO (1) WO2001000582A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6417366B2 (en) * 1999-06-24 2002-07-09 Abbott Laboratories Preparation of quinoline-substituted carbonate and carbamate derivatives
WO2005070918A1 (en) 2002-05-13 2005-08-04 Enanta Pharmaceuticals, Inc. Process for the preparation of t-11 bicyclic erythromycin derivatives
US7135573B2 (en) 2002-05-13 2006-11-14 Enanta Pharmaceuticals, Inc. Processes for the preparation of O-(6-Pyrazol-1-yl-pyridin-3-ylmethyl)-hydroxylamine
US7910558B2 (en) 2002-05-13 2011-03-22 Enanta Pharmaceuticals, Inc. Bridged macrocyclic compounds and processes for the preparation thereof
US7595300B2 (en) 2005-12-13 2009-09-29 Kosan Biosciences Incorporated 7-quinolyl ketolide antibacterial agents
US8871728B2 (en) 2007-06-29 2014-10-28 Georgia Tech Research Corporation Non-peptide macrocyclic histone deacetylese (HDAC) inhibitors and methods of making and using thereof
WO2009006403A2 (en) * 2007-06-29 2009-01-08 Georgia Tech Research Corporation Non-peptide macrocyclic histone deacetylase (hdac) inhibitors and methods of making and using thereof
CN102741206B (zh) * 2010-01-28 2016-02-10 帝斯曼知识产权资产管理有限公司 氢化方法
CN102766091A (zh) * 2011-05-06 2012-11-07 上海医药工业研究院 3-(3-喹啉基)-2-丙炔-1-醇的制备方法
US10443146B2 (en) * 2017-03-30 2019-10-15 Lam Research Corporation Monitoring surface oxide on seed layers during electroplating
CN115650824B (zh) * 2022-10-31 2024-01-23 合肥工业大学 手性二醇及其制备方法、制得的催化剂及制备方法和应用
CN117643897B (zh) * 2024-01-29 2024-05-03 成都岷山绿氢能源有限公司 用于n-杂环的选择性半氢化催化剂及其制备方法

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2448047A (en) * 1947-02-15 1948-08-31 Burton T Bush Inc Preparation of unsaturated alcohols
DE2554790A1 (de) 1974-12-26 1976-07-01 Uniroyal Inc Tetrasubstituierte zinnorganische verbindungen
US4154834A (en) 1975-12-29 1979-05-15 Smith Kline & French Laboratories Limited Substituted isocytosines having histamine H2 -antagonist activity
MW5076A1 (en) * 1975-12-29 1978-02-08 Smith Kline French Lab Pharmacologicalle active compounds
US4217298A (en) 1977-09-05 1980-08-12 Tokuyama Soda Kabushiki Kaisha Process for preparing organic carbonates
US4331803A (en) 1980-06-04 1982-05-25 Taisho Pharmaceutical Co., Ltd. Novel erythromycin compounds
HU197881B (en) 1982-08-06 1989-06-28 Banyu Pharma Co Ltd Process for producing new carbamoyl-oxy-alkyl-carboxy-lic acid derivatives
EP0216869A1 (de) 1985-03-27 1987-04-08 Walter Basta Wärmemengenmessgerät
GB8612361D0 (en) 1986-05-21 1986-06-25 Engelhard Corp Gold electroplating bath
US4761419A (en) * 1987-12-07 1988-08-02 Warner-Lambert Company 6-(((substituted)quinolinyl)ethyl)-and ethenyl)tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis
DE3820775A1 (de) * 1988-06-20 1989-12-21 Thomae Gmbh Dr K Neue 4,5,7,8-tetrahydro-6h-thiazolo(5,4,-d)azepine, ihre herstellung und ihre verwendung als arzneimittel
US5753675A (en) * 1989-03-03 1998-05-19 Novartis Pharmaceuticals Corporation Quinoline analogs of mevalonolactone and derivatives thereof
US5128448A (en) 1990-01-10 1992-07-07 Hoffman-La Roche Inc. CCK analogs with appetite regulating activity
US5200547A (en) 1990-09-04 1993-04-06 Monsanto Company Preparation of urethane and carbonate products
US5334597A (en) * 1991-10-17 1994-08-02 Merck Frosst Canada, Inc. Indole carbamates as leukotriene antagonists
US5374755A (en) 1992-07-17 1994-12-20 Millipore Corporation Liquid chromatography stationary phases with reduced silanol interactions
DE4318889A1 (de) * 1993-06-07 1994-12-08 Bayer Ag Verfahren zur Herstellung von organischen Carbamaten
CA2188809A1 (en) 1994-05-13 1995-11-23 Gee-Hong Kuo Therapeutic phenoxyalkylazoles and phenoxyalkylazines
KR970707098A (ko) * 1994-10-27 1997-12-01 후지야마 아키라 브라디키닌 길항제로서 피리도피리미돈, 퀴놀린 및 융합된 N-헤테로사이클(Pyridopyrimidones, quinolines and fused N-heterocycles as bradykinin antagonists)
FR2744303B1 (fr) 1996-01-31 1998-03-27 Sgs Thomson Microelectronics Dispositif pour neutraliser un circuit electronique lors de sa mise sous tension ou sa mise hors tension
JP4278008B2 (ja) 1996-08-23 2009-06-10 興和株式会社 ジアミド化合物及びこれを含有する医薬
UA51730C2 (uk) 1996-09-04 2002-12-16 Ебботт Лабораторіз 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців
ATE296831T1 (de) * 1996-09-04 2005-06-15 Abbott Lab 6-0-substituierte ketoliden mit antibakteriellen wirkung
US5919776A (en) * 1996-12-20 1999-07-06 Merck & Co., Inc. Substituted aminoquinolines as modulators of chemokine receptor activity
JPH10291981A (ja) * 1997-02-21 1998-11-04 Takeda Chem Ind Ltd 縮合環化合物、その製造法および用途
WO1998037070A1 (en) * 1997-02-21 1998-08-27 Takeda Chemical Industries, Ltd. Fused ring compounds, process for producing the same and use thereof
ZA983930B (en) 1997-05-14 1999-11-08 Lilly Co Eli Excitatory amino acid receptor modulators.
AU7937998A (en) 1997-07-08 1999-02-08 Sankyo Company Limited Antifungal triazole compounds
US6437106B1 (en) * 1999-06-24 2002-08-20 Abbott Laboratories Process for preparing 6-o-substituted erythromycin derivatives
US6417366B2 (en) * 1999-06-24 2002-07-09 Abbott Laboratories Preparation of quinoline-substituted carbonate and carbamate derivatives
US6455680B1 (en) * 2000-12-21 2002-09-24 Abbott Laboratories Methods utilizing aryl thioimines in synthesis of erythromycin derivatives

Also Published As

Publication number Publication date
CN1217934C (zh) 2005-09-07
US6579986B2 (en) 2003-06-17
PT1192139E (pt) 2012-07-20
CY1113070T1 (el) 2016-04-13
IL146475A (en) 2011-02-28
CA2850203A1 (en) 2001-01-04
WO2001000582A1 (en) 2001-01-04
US6417366B2 (en) 2002-07-09
CN1370148A (zh) 2002-09-18
DK2261212T3 (da) 2017-01-02
EP1192139B1 (de) 2012-04-18
PT2261212T (pt) 2016-12-16
US7074932B2 (en) 2006-07-11
EP2261212A2 (de) 2010-12-15
MXPA01013209A (es) 2002-06-21
CY1118338T1 (el) 2017-06-28
ES2605791T3 (es) 2017-03-16
IL201850A (en) 2011-09-27
JP5302291B2 (ja) 2013-10-02
US20020013468A1 (en) 2002-01-31
CA2368768C (en) 2011-10-11
CA2719425A1 (en) 2001-01-04
HK1047089B (en) 2012-08-31
US20030199696A1 (en) 2003-10-23
CA2719425C (en) 2014-08-12
EP2261212B1 (de) 2016-08-31
EP2409964B1 (de) 2016-01-27
AU784291B2 (en) 2006-03-02
EP2409964A2 (de) 2012-01-25
EP1192139A1 (de) 2002-04-03
KR20020025903A (ko) 2002-04-04
CN1663952A (zh) 2005-09-07
JP2003503388A (ja) 2003-01-28
EP2261212A3 (de) 2014-12-31
IL208674A0 (en) 2010-12-30
ES2565954T3 (es) 2016-04-07
CN100355734C (zh) 2007-12-19
US20060128962A1 (en) 2006-06-15
HK1166973A1 (en) 2012-11-16
US20020165390A1 (en) 2002-11-07
AU5739300A (en) 2001-01-31
IL146475A0 (en) 2002-07-25
DK1192139T3 (da) 2012-07-23
JP2011088904A (ja) 2011-05-06
EP2409964A3 (de) 2013-07-31
IL208674A (en) 2014-09-30
CA2368768A1 (en) 2001-01-04
KR100666291B1 (ko) 2007-01-11
JP4724337B2 (ja) 2011-07-13
ES2385963T3 (es) 2012-08-06
HK1047089A1 (en) 2003-02-07

Similar Documents

Publication Publication Date Title
CY1118338T1 (el) Παρασκευη κινολινο-υποκατεστημενων καρβαμικων παραγωγων
CA2334773A1 (en) Benzothiepine-1,1-dioxide derivatives, method for producing them, medicaments containing these compounds and their use
DE50005437D1 (en) Substituierte thien-3-yl-sulfonylamino(thio)carbonyl-triazolin(thi)one
BR9909844A (pt) Processo para sintetizar um composto, e, composto.
BR9912104B1 (pt) compostos derivados de quinolina, composições farmacêuticas, e, processo para a manufatura de um composto.
BR9909739A (pt) Benzotiadiazóis e derivados
ATE252584T1 (de) Carbapenem-antibiotikum, zusammensetzung und ihre herstellung
IT1307267B1 (it) Procedimento di rafforzamento di attivita' antitumorale di farmacigrezzi, composizione contenente un farmaco grezzo rafforzante
WO2002092602A3 (en) PROCESSES FOR THE SYNTHESIS OF DERIVATIVES OF 2,3-DIHYDRO-1,4-DIOXINO-[2,3-f] QUINOLINE
DE69925992D1 (de) VERFAHREN ZUR HERSTELLUNG VON 5-HYDROXYBENZO[b]THIOPHEN-3-CARBONSÄURE
ATE290096T1 (de) Coenzym zur herstellung von l-carnitin
BR0013094B1 (pt) processo para a preparação de compostos 1,3-dicarbonìlicos acilados.
DK0677513T3 (da) Octahydro-2-naphthalencarboxylsyrederivat, dets fremstilling og anvendelse
ZA200104304B (en) Carbamate derivatives of diaryl 1,3,4-oxadiazolone.
BR0112849A (pt) Processo para a preparação de um composto quiral, e, composto quiral
MXPA04001852A (es) Uso de sistemas indan-1-ol c2-sustituidas para la produccion de medicamentos para la profilaxis o tratamiento de obesidad.
MXPA04001856A (es) Indan-1-oles c2-sustituidos y sus derivados, metodo para su produccion y su uso como medicamentos.
WO2003020677A3 (de) C2-substituierte indan-1-one und ihre derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
MXPA04001851A (es) Inda-1-onas c2-disustituidas y sus derivados, metodo para su produccion y su uso como medicamentos.
DE69904940D1 (de) 6-deoxy-erythromycin-derivate, ihrer herstellung, und ihrer verwendung als arzneimitteln
IT1304178B1 (it) Procedimento per la sintesi di uretonimmine a partire da isocianati.
TH41471A (th) อนุพันธ์พิเพอริดินิลเมทิลออกซาโซลิดิโนน
DE69816095D1 (de) Herstellung von beta-mehtylcarbapenem-zwischenprodukten
ITFI990166A0 (it) Processo per sintesi biocatalizzate.
ECSP982770A (es) Nuevos uretanos sus analogos tio y ditio, sus sales, medicamentos que contienen estos compuestos y su empleo asi como procedimientos para su preparacion